Farglitazar Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Farglitazar is a peroxisome proliferator-activated receptor (PPAR) agonist and has been explored for treating hepatic fibrosis and type 2 diabetes.

Farglitazar Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Farglitazar Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32466	58
Nextpeptide Inc	+86-0571-81612335 +8613336028439	sales@nextpeptide.com	China	19908	58
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12335	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44909	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11972	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	29867	58
Shanghai Amole Biotechnology Co., Ltd.	18017925202 18916960931	2596183085@qq.com	China	17238	58

---

• Farglitazar
• 2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid
• G1 262570
• GI 262570
• GI 262570X
• N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine
• L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-
• (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid
• 196808-45-4